Suppr超能文献

2020年西班牙一项利用医院出院数据的回顾性队列研究:2型糖尿病对因COVID-19需住院治疗的发病率及结局的影响(按性别分析)

Impact of Type 2 Diabetes Mellitus on the Incidence and Outcomes of COVID-19 Needing Hospital Admission According to Sex: Retrospective Cohort Study Using Hospital Discharge Data in Spain, Year 2020.

作者信息

de Miguel-Yanes Jose M, Jimenez-Garcia Rodrigo, de Miguel-Diez Javier, Hernández-Barrera Valentin, Carabantes-Alarcon David, Zamorano-Leon Jose J, Omaña-Palanco Ricardo, Lopez-de-Andres Ana

机构信息

Internal Medicine Department, Hospital General Gregorio Marañón, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), 28007 Madrid, Spain.

Department of Public Health & Maternal and Child Health, Faculty of Medicine, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Gregorio Marañón (IdISSC), 28040 Madrid, Spain.

出版信息

J Clin Med. 2022 May 9;11(9):2654. doi: 10.3390/jcm11092654.

Abstract

(1) Background: To analyze incidence and in-hospital mortality (IHM) of COVID-19 needing hospital admission in Spain (2020) in patients with T2DM. (2) Methods: We conducted a retrospective cohort study. Using the Spanish Register of Specialized Care-Basic Minimum Database we estimated age-adjusted incidence rates (IR). (3) Results: We included 203,488 patients (56.77% men), of whom 45,620 (22.41%) had T2DM. Age-adjusted IRs/1000 for men with and without T2DM was 12.90 and 5.87, respectively (IRR 2.20; 95% CI 2.18−2.22; p < 0.001), and for women with and without T2DM was 9.23 and 4.27, respectively (IRR 2.16; 95% CI 2.13−2.19; p < 0.001). Crude IHM was 23.86% in people with T2DM, and 15.94% in non-T2DM people (p < 0.001). After matching, intensive-care admission (7.37% vs. 6.15%; p < 0.001) and IHM (23.37% vs. 20.41%; p < 0.001) remained higher in women with T2DM. After matching, IHM among T2DM men was 1.5% higher than among non-T2DM men (24.27% vs. 22.72%; p < 0.001). Men with T2DM had a 34% higher IHM than women with T2DM. Prevalent T2DM increased IHM among women (1.09; 95% 1.03−1.16) and men (1.05; 95% 1.01−1.10). (4) Conclusions: Incidence rates of COVID-19 needing hospital admission were higher in men vs. women, and for people with T2DM vs. non-T2DM. Men had higher IHM beside T2DM status. Prevalent T2DM was associated with higher IHM for both sexes.

摘要

(1) 背景:分析2020年西班牙需要住院治疗的2型糖尿病(T2DM)患者中新型冠状病毒肺炎(COVID-19)的发病率及住院死亡率(IHM)。(2) 方法:我们进行了一项回顾性队列研究。利用西班牙专科护理登记册 - 基本最小数据库,我们估算了年龄调整发病率(IR)。(3) 结果:我们纳入了203,488例患者(56.77%为男性),其中45,620例(22.41%)患有T2DM。患有和未患有T2DM的男性年龄调整后的每1000人发病率分别为12.90和5.87(发病率比[IRR] 2.20;95%置信区间[CI] 2.18 - 2.22;p < 0.001),患有和未患有T2DM的女性分别为9.23和4.27(IRR 2.16;95% CI 2.13 - 2.19;p < 0.001)。T2DM患者的粗住院死亡率为23.86%,非T2DM患者为15.94%(p < 0.001)。匹配后,患有T2DM的女性重症监护病房入住率(7.37%对6.15%;p < 0.001)和住院死亡率(23.37%对20.41%;p < 0.001)仍然更高。匹配后,T2DM男性的住院死亡率比非T2DM男性高1.5%(24.27%对22.72%;p < 0.001)。患有T2DM的男性住院死亡率比患有T2DM的女性高34%。患T2DM会增加女性(1.09;95% 1.03 - 1.16)和男性(1.05;95% 1.01 - 1.10)的住院死亡率。(4) 结论:需要住院治疗的COVID-19发病率男性高于女性,T2DM患者高于非T2DM患者。无论T2DM状态如何,男性的住院死亡率都更高。患T2DM与两性更高的住院死亡率相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95cd/9104185/aeee9b71313e/jcm-11-02654-g001.jpg

相似文献

本文引用的文献

2
[Case-fatality rates of SARS-CoV-2 infection according to Autonomous Communities during the second epidemic wave in Spain].
Semergen. 2022 May-Jun;48(4):252-262. doi: 10.1016/j.semerg.2022.02.004. Epub 2022 Feb 18.
5
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.
N Engl J Med. 2022 Jan 27;386(4):305-315. doi: 10.1056/NEJMoa2116846. Epub 2021 Dec 22.
6
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients.
N Engl J Med. 2022 Feb 10;386(6):509-520. doi: 10.1056/NEJMoa2116044. Epub 2021 Dec 16.
10
Systemic corticosteroids for the treatment of COVID-19.
Cochrane Database Syst Rev. 2021 Aug 16;8(8):CD014963. doi: 10.1002/14651858.CD014963.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验